SCYNEXIS Inc (SCYX)
2.42
+0.07
(+2.98%)
USD |
NASDAQ |
May 31, 16:00
2.40
-0.02
(-0.83%)
After-Hours: 20:00
SCYNEXIS Total Assets (Quarterly): 118.25M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 118.25M |
| December 31, 2023 | 128.41M |
| September 30, 2023 | 148.55M |
| June 30, 2023 | 154.86M |
| March 31, 2023 | 70.30M |
| December 31, 2022 | 87.81M |
| September 30, 2022 | 112.29M |
| June 30, 2022 | 135.61M |
| March 31, 2022 | 111.56M |
| December 31, 2021 | 119.84M |
| September 30, 2021 | 109.88M |
| June 30, 2021 | 121.13M |
| March 31, 2021 | 100.07M |
| December 31, 2020 | 102.54M |
| September 30, 2020 | 36.75M |
| June 30, 2020 | 45.27M |
| March 31, 2020 | 41.51M |
| December 31, 2019 | 57.15M |
| September 30, 2019 | 33.82M |
| June 30, 2019 | 41.07M |
| March 31, 2019 | 45.07M |
| Date | Value |
|---|---|
| December 31, 2018 | 53.17M |
| September 30, 2018 | 51.65M |
| June 30, 2018 | 58.05M |
| March 31, 2018 | 65.49M |
| December 31, 2017 | 45.85M |
| September 30, 2017 | 49.62M |
| June 30, 2017 | 51.84M |
| March 31, 2017 | 56.66M |
| December 31, 2016 | 59.79M |
| September 30, 2016 | 61.01M |
| June 30, 2016 | 53.52M |
| March 31, 2016 | 40.68M |
| December 31, 2015 | 49.27M |
| September 30, 2015 | 56.10M |
| June 30, 2015 | 64.68M |
| March 31, 2015 | 34.86M |
| December 31, 2014 | 39.67M |
| September 30, 2014 | 41.96M |
| June 30, 2014 | 45.96M |
| March 31, 2014 | 12.98M |
| December 31, 2013 | 12.39M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
33.82M
Minimum
Sep 2019
154.86M
Maximum
Jun 2023
93.83M
Average
106.21M
Median
Total Assets (Quarterly) Benchmarks
| Bioventus Inc | 794.24M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 48.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 44.15M |
| Shareholders Equity (Quarterly) | 74.10M |
| Current Ratio | 3.718 |
| Net Debt Paydown Yield | 16.35% |